Response to letter to the Editors-Safety of long-term denosumab therapy

Support Care Cancer. 2017 Feb;25(2):353-355. doi: 10.1007/s00520-016-3492-8. Epub 2016 Nov 24.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Bone Density
  • Bone Density Conservation Agents*
  • Denosumab*
  • Humans

Substances

  • Bone Density Conservation Agents
  • Denosumab